脑肿瘤复发的代谢成像
本文讨论脑肿瘤复发诊断的难点,指出MRI结构分辨率高但诊断复发可靠性相对较低,代谢成像对复发早期改变更敏感且相对不受治疗相关变化干扰,结论认为不存在一站式诊断方法,代谢成像的敏感性不能替代MRI的分辨率,多模态方法是唯一出路。
要点
- MRI结构分辨率高但诊断肿瘤复发的可靠性相对低于代谢成像。
- 代谢成像对复发早期改变更敏感,且相对不受治疗相关变化干扰。
- 脑肿瘤复发诊断无单一方法可替代,需多模态联合。
核心结论
- 脑肿瘤复发的诊断不存在一站式方法,代谢成像的敏感性不能替代MRI的分辨率,多模态方法是唯一出路。
研究设计与样本
- 本文为综述/论述性文章,未报告系统检索范围、纳入文献数量、样本量或参考标准。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE. Diagnosing brain tumor recurrence, especially with changes that occur after treatment, is a challenge. MRI has an exceptional structural resolution, which is important from the perspective of treatment planning. However, its reliability in diagnosing recurrence is relatively lower, when compared to metabolic imaging. The latter is more sensitive to the early changes associated with recurrence and relatively immune to confounding by treatment related changes. CONCLUSION. There is no one-stop shop for the diagnosis of recurrence in brain tumors. The sensitivity of metabolic imaging is not a substitute for the resolution of the MRI, making a multi-modal approach the only way forward.
引用
- Sharma A, Kumar R. Metabolic Imaging of Brain Tumor Recurrence. AJR Am J Roentgenol. 2020. PMID: 32960666. doi:10.2214/AJR.19.22624
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。